Happy Humpday! Exit Only (Pink: EXTO) Is The Rally Over? Zoom technologies (ZOOM) technical update!

Happy humpday mi amors!

As the oil sector rallied yesterday on worries over Iran and Greece, Exit only (Pink: EXTO) aka Bayport Corporation a well known stinky pinky holdings group with a strong focus on crude also benefited as the stock went on a tear from .006 to .009 before settling back down to close right at a former resistance and now tentative support level of .0075.

We covered EXTO back in Dec. at an all you could eat buffet of shares at an avg. price of .0055, so that’s a gain upwards of 80% in 2 months! So if you are one of the patient roaches that sat on a few shares of EXTO (and I know there’s quite a few of you lurking around) it’s almost like found money! Cha-ching!

EXTO coverage from Dec. http://www.stockroach.com/senoritas-humpday-special-is-exit-only-inc-pink-exto/

Does your Senorita think that the rally at EXTO can continue? Well, the charts say, “Yes it can.” and with buys outnumbering sells by almost 5:1 during yesterday’s trading, the chart is getting mucho caliente. There’s the beautiful MACD divergence starting, the RSI is in the trader “buy zone” of the 50s, the wick on the candle is a bit longer than I would prefer, but with EXTO a wick that long just shows me that those that have been holding for a few months might have just taken some off the table.  Take a look at EXTO’s beautiful chart. http://stockcharts.com/h-sc/ui?s=EXTO&p=D&b=5&g=0&id=p01518581551

Support for EXTO comes in at .0075, with a lower level support of .006, and resistances lies ahead at .009, and .01.

Zoom technologies, inc. (Nasdaq: ZOOM) might be ready to go zoom, zoom, zoom and I will get to the techs after this REMINDER:

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in.  Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to join the thousands of other roaches on Twitter for intraday plays, and for heads up tweets when things get  HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Zoom technologies, inc (Nasdaq: ZOOM) was my alert on Friday where there were plenty of shares at $1.30 – $1.32 and let me tell you my darlings that this puppy trades thin. 210K in volume ticks this sucker up a few pennies so I would like to see what it can do with some real volume. It appears that ZOOM will be tackling that $1.40 resistance sometime today. The techs from Friday are still in place.

Support for ZOOM comes in at $1.30 with a lower support level of $1.20, resistances lies ahead at $1.40, $1.50, and then it looks like it’s bluesky territory after $1.70.

For those that missed the ZOOM blog: http://www.stockroach.com/senorita-takes-a-look-at-zoom-technologies-inc-nasdaq-zoom-tech-updates-for-bpax-and-cbrx/

There’s a beautiful pincher on the MACD, and the buying volume is starting to get a bit heavier as well which is reflected in the RSI.

ZOOM chart: http://stockcharts.com/h-sc/ui?s=ZOOM&p=D&b=5&g=0&id=p71867454122

I’m really table pounding ZOOM guys and gals, and you know what happens when Senorita keeps pounding the table…..that’s right, the saavy roaches tend to rake it in while everyone ends up chasing  at a higher PPS or misses out completely haha.

Senorita “Rockin’ Wall St.” Roachita

Continue reading»

FROG captures Pam Anderson’s va-va-voom

Traders Do The Jumping As Pammie Joins The FROG! Happy Carnival, Roaches! I’ve kept a close eye on FrogAds, Inc. (FROG) since the year started to let you know whenever conditions favored a big leap. Every alert so far has put 10% to 30% in traders’ pockets, sometimes across two- or three-day rallies. And I’m [...]...

Continue reading »

Eat some Mardi Gras “cake” today!

Good Morning, Trader! Your batteries should be charged and fresh to take on today’s red hot alert. It’s a stock that has the weight of headlines and hoopla behind it: an easy-to-explain business model in arguably the hottest sector of the year. Management is keeping the market up to date on every little milestone, giving [...]...

Continue reading »

This Trader has Found a Trick for Beating the Market

Traders are Getting Rich Following SuperNova Stocks Good Afternoon Trader! With Monday being a market holiday, I wanted to take advantage of this time to remind you of a phenomenal opportunity that more than a thousand traders have already discovered to beat this market. If you remember a short while ago, I tipped you off [...]...

Continue reading »

Senorita Takes A Look at Zoom Technologies, Inc. (Nasdaq: ZOOM). Tech Updates For BPAX And CBRX!

TGIF mi amors! Today your Senorita is taking a look at a stock that is in such a sizzling hot sector that I give a 5 jalapeno salute to this spicy enchilada!...

Continue reading »

Roaches, get ready to FLY!

This Little Wonder Should Kick-Start Your Holiday Weekend!

Good Evening, Trader!

I know it’s a three-day weekend but keep that “trader” hat on tomorrow morning, because I’ve got another Friday Special on the menu and this one’s coming in HOT.

Yes! It’s been a big week around here — multiple alerts, multiple DOUBLE-DIGIT paydays — so let’s set off one more firecracker!

This company’s been around for decades and has a very high-end clientele. In fact, those world-class customers helped create the latest wave of products, so it’s a pretty good bet that they’re already “predisposed” to buy more.

Throughout that long time frame, traders who wanted exposure to this company’s unique story just couldn’t do it — shares weren’t available!

All that changed about 3 weeks ago. Suddenly, these shares were floating as free as any other under-a-dime stock and traders went berserk to get their piece of the action.

By my calculations, turnover here is up a healthy 500% in February alone, and the trend has been pointing toward the sky.

Something’s making traders jump over themselves for a shot at this ticker!
I won’t sleep until I find out. As for you, set your alarm and be ready to trade!

Papa Roach

Continue reading»

BCDH is giving the Roach plenty “synergy”

Good morning, Roachland!

Black Castle Developments Holding, Inc. (BCDH) is evolving into a real pint-sized conglomerate…and the “synergy” is already driving traders into a frenzy!

Take a look at those volume bars. Turnover is up 30 to 1 so far this month as BCDH makes good on its ambitions:

You’ll note that BCDH price action hasn’t exactly gone up 3,000% as yet.

Maybe this is one of those cases where “price FOLLOWS volume,” I don’t know.

What I do know is that up/down on BCDH shows 80% more buyers than sellers, mostly on that home run the stock hit last Wednesday.

After that, the trend lines are all crammed up around $0.06 to $0.09, so the right swing could easily break all the resistance points in one shot!

So what does BCDH do, Papa Roach?

Leading off with the sexiest of BCDH’s subsidiaries — a company called bizM3 — traders looking for a ground-floor chance to get into the white-hot mobile marketing industry will find it here. (Read more)

After all, sending marketing messages to mobile devices is what turned Groupon into a $10 BILLION dot-com empire.

I bet the guys who got into Groupon early are living easy now!

And the specific business opportunity BCDH is targeting here is already reckoned in the billions and DOUBLING every year! (Read more)

BCDH is already more than the sum of its parts

Now if that was all BCDH was about, it might be enough to get it in front of you.

But BCDH is also an business development incubator, which means management looks for acquisitions it can push together and generate more money off the sum of the parts.

Example: Now that BCDH has committed to buy bizM3, it’s steering the business toward hotels, restaurants, other “hospitality” customers. (Read more)

Meanwhile, BCDH just bought A-Shine, Inc., an established niche technology provider to the hospitality industry! (Read more)
Take A-Shine’s customers and feed them to bizM3′s sales team, and suddenly both businesses have a huge competitive edge.

That’s the kind of “synergy” traders are leaping into BCDH to capture for themselves!

And BCDH has a secret weapon!

BCDH had $800,000 in prime California residential property on its books in its last earnings statement — and that creates a solid base for future moves.

Billion-dollar upside potential…synergy…a portfolio of hard assets on the bottom.

That’s the BCDH proposition. Take a look this morning. Maybe the sizzle and the steak are on your menu?Papa Roach

 

 

 

 

 

Jason Bond makes a killing on 3 simple trades each week ANYONE can follow. His real money verified trades are up 36% in the past 52 weeks. Learn how to profit from Jason.

 

 

 

 

 

 

 

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. BlueWave Advisors has been compensated fifteen thousand dollars from Odd Marketing (a non-controlling third party shareholder) for BCDH advertising and promotion. Stockhdeout LLC has been compensated seven thousand five hundred dollars from BlueWave Advisors (a non-affiliated third party) for BCDH advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

HWIC is today’s Roach Alert

Good morning!

You might remember HWIC Global, Inc. (HWIC) from the big 30% to 40% wins this “clean room” manufacturer earned us awhile back.

But while HWIC has made quite a few traders some handsome cash, its chart spent the last few months filling in the gaps.

But that was before Monday’s massive move put HWIC back on the market’s map!

See for yourself:

The entire market can read those lines perfectly well: HWIC is in play!

Fact is, traders were already intrigued at how HWIC kept signing massively lucrative contracts with the world’s leading hospitals, laboratories and manufacturers…at about $140 per square foot! (Read more)

That’s not exactly cheap, and these aren’t tiny closets we’re talking about, either, so HWIC is rolling in revenue on every deal that comes in.

Some of these facilities can get into the 10,000 square-foot range — that’s a 1/4 acre filled with hi-tech proprietary PVC walls, vents, power and HVAC, all included for maybe $1.4 MILLION. (Read more)

No wonder HWIC got to brag in its latest quarterly numbers that sales are up 80% on a year-over-year basis! (Read more)
HWIC has woken up…and is reaching for the sky!

But late last year, HWIC‘s normally “frisky” chart became an all-out battlefield as the shorts who controlled about 50% of the turnover ran into entrenched opposition and sent shares swinging 60% a day.

Now, according to FINRA filings, HWIC shorts have finally admitted defeat…and when I saw where the price action had come to rest, I knew I had to get this stock in front of you FAST!

You see, whenever HWIC has dipped to the $0.01 to $0.011 level in the recent past, these shares were trading back up at $0.024 to $0.03 the very next session!

Sure enough, HWIC got its first dose of 3-digit action in ages yesterday, a history-making move that broke all the way up above $0.05.

So where do we go from here? Keep an eye on HWIC this morning…and find out!Papa Roach

Continue reading»

Calling all amigos to a favorite in “motion”

Good Evening!

Listen up, because it’s going to get hot and heavy around here in the next few days.

Tomorrow’s alert is a niche player in some extremely high-growth markets, with some of the world’s most prestigious clients lined up for its products.
Under the right circumstances, the stock generated anywhere from 30% to over 100% a day for traders in the know.

But those “circumstances” just weren’t happening, leaving the price action in limbo…until yesterday.

Just 24 hours ago, lightning hit this stock and made it start paying out again.

Paying out BIG.

That’s when I knew I had to scamper to get this stock back in front of you.

Set the alarm and be ready for those bells to start ringing!

Papa Roach

Continue reading»

Teva, BioSante Win FDA Approval to Sell Men’s Testosterone-Replacement Gel

 

Teva Pharmaceutical Industries Ltd. (TEVA)and BioSante Pharmaceuticals Inc. (BPAX) won U.S. clearance to sell Bio-T-Gel, a testosterone replacement therapy for men.

The Food and Drug Administration approved the transdermal gel, the agency said today in an e-mail. Teva, of Petach Tikva, Israel, will market Bio-T-Gel for men with low testosterone. The condition, known as hypogonadism, can cause erectile dysfunction, infertility, osteoporosis and muscle loss, according to the Mayo Clinic in Rochester, Minnesota.

BioSante, the original developer of Bio-T-Gel, estimates the market for male testosterone products is more than $1.2 billion in the U.S., where hypogonadism affects as many as 5 million men. BioSante, of Lincolnshire, Illinois, licensed the gel to Teva, the world’s largest generic-drug maker, and will receive milestone payments and royalties when the drug is commercialized.

Abbott Laboratories (ABT) won FDA approval in April for a testosterone product known as AndroGel and later sued Teva, alleging that Bio-T-Gel infringed the product’s patent. Abbott, of Abbott Park, Illinois, and Teva settled the litigation in December without disclosing the terms, BioSante said Jan. 31 in a statement.

BioSante’s other experimental testosterone product, LibiGel, is a topical treatment applied to the arm for female sexual dysfunction. The company fell 77 percent, the most in 12 years, on Dec. 15 after the drug failed to work better than a placebo in two trials. BioSante said Jan. 31 that it would decide within 90 days whether to continue studying LibiGel.

To contact the reporter on this story: Molly Peterson in Washington at mpeterson9@bloomberg.net

To contact the editor responsible for this story: Adriel Bettelheim at abettelheim@bloomberg.net

Continue reading»